We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Penny
Bee
penny.e.bee@manchester.ac.uk
Andrew
Grundy
andrew.grundy@manchester.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Schizophrenia, schizotypal and delusional disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Background:
People who are prescribed antipsychotics report that they often experience changes in their hunger, appetite, or the extent to which they feel satisfied after a meal. They also say that these experiences feel very different to usual hunger and are much harder to control. We want to understand this experience of hunger and to identify support options to help people manage it.
Aim:
To develop a non-medication support-package to help service users manage the hunger side-effects of antipsychotics.
Mixed Methods:
In phase 1, we will first conduct semi-structured interviews with up to 30 mental health service users. We will then conduct focus groups with up to 30 carers and focus groups with up to 30 mental health and social care professionals. These will help us to understand people’s perspectives and experiences of hunger side-effects, their preferred support options, and their ideas around how a support-package might be designed and delivered. Alongside this work, we will conduct a national survey to further ascertain the nature and scale of these hunger side-effects.
In phase 2, we will run workshops where we will aim to seek agreement on the content, format, and delivery of the support-package.
Contribution:
We aim to devise a support-package that will be acceptable to service users, carers, and health professionals, in managing the hunger side-effects of antipsychotics. Our next steps would be to obtain further funding to test whether the support-package is feasible and clinically and cost effective.
Funder:
NIHR Applied Research Collaboration – Greater Manchester (ARC-GM)
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cross-sectional;
You can take part if:
You may not be able to take part if:
SERVICE USERS - NATIONAL SURVEY • Service users living outside the UK SERVICE USERS – PHASE 1 INTERVIEWS & PHASE 2B WORKSHOPS • Service users who lack capacity to consent to participation. • Service users that have not started (or changed to) a new antipsychotic medication within the previous 12 months • Service users diagnosed with an eating disorder, autism or dementia, due to these conditions being associated with changes in dietary behaviours • Service users diagnosed with a severe or profound learning disability (service users with mild/moderate learning disabilities will be eligible), providing they are able to give informed consent. • Living outside the UK CARERS – PHASE 1 INTERVIEWS & PHASE 2B WORKSHOPS • Living outside the UK PROFESSIONALS– PHASE 1 INTERVIEWS & PHASE 2B WORKSHOPS • Working in Early Intervention services outside the UK
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Penny
Bee
penny.e.bee@manchester.ac.uk
Andrew
Grundy
andrew.grundy@manchester.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Manchester and funded by NIHR Applied Research Collaboration Greater Manchester .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 54045
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
